Correlation Between Allena Pharmaceuticals and Akari Therapeutics

Can any of the company-specific risk be diversified away by investing in both Allena Pharmaceuticals and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Allena Pharmaceuticals and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Allena Pharmaceuticals and Akari Therapeutics PLC, you can compare the effects of market volatilities on Allena Pharmaceuticals and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Allena Pharmaceuticals with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Allena Pharmaceuticals and Akari Therapeutics.

Diversification Opportunities for Allena Pharmaceuticals and Akari Therapeutics

0.0

Correlation Coefficient

Allena Pharmaceuticals  Akari Therapeutics

Pay attention - limited upside

The 3 months correlation between Allena and Akari is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Allena Pharmaceuticals and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and Allena Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Allena Pharmaceuticals are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of Allena Pharmaceuticals i.e., Allena Pharmaceuticals and Akari Therapeutics go up and down completely randomly.

Pair Corralation between Allena Pharmaceuticals and Akari Therapeutics

If you would invest  100.00  in Akari Therapeutics PLC on December 28, 2024 and sell it today you would earn a total of  27.00  from holding Akari Therapeutics PLC or generate 27.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Allena Pharmaceuticals  vs.  Akari Therapeutics PLC

Allena Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Allena Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Allena Pharmaceuticals is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Akari Therapeutics PLC

Risk-Adjusted Performance

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Akari Therapeutics PLC are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Akari Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Allena Pharmaceuticals and Akari Therapeutics

The main advantage of trading using opposite Allena Pharmaceuticals and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Allena Pharmaceuticals position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.

The idea behind Allena Pharmaceuticals and Akari Therapeutics PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.